Skip to content
10-Q

Quarterly Report

Durata Therapeutics, Inc.

0001193125-14-402186

← back to feed
Filed
Nov 7, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 31, 2014 26.79M sh
Capex Q3 2014 · Sep 30, 2014 $1.05M
Capex restated Q3 2014 · Sep 30, 2013 $439K
Long Term Debt Q3 2014 · Sep 30, 2014 $63.5M
Long Term Debt Q3 2014 · Dec 31, 2013 $25M
Short Term Debt Q3 2014 · Sep 30, 2014 $1.5M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $27.67M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $36.85M
Cash And Equivalents restated Q3 2014 · Sep 30, 2013 $44.49M
Cash And Equivalents restated Q3 2014 · Dec 31, 2012 $32.26M
Stockholders Equity Q3 2014 · Sep 30, 2014 −$16.08M
Stockholders Equity Q3 2014 · Dec 31, 2013 $38.58M
Current Liabilities Q3 2014 · Sep 30, 2014 $32.67M
Current Liabilities Q3 2014 · Dec 31, 2013 $14M
Total Liabilities Q3 2014 · Sep 30, 2014 $98.2M
Total Liabilities Q3 2014 · Dec 31, 2013 $61.57M
Current Assets Q3 2014 · Sep 30, 2014 $44.34M
Current Assets Q3 2014 · Dec 31, 2013 $63.1M
Total Assets Q3 2014 · Sep 30, 2014 $82.12M
Total Assets Q3 2014 · Dec 31, 2013 $100.14M
Sga Expense Q3 2014 · Sep 30, 2014 $16.7M
Sga Expense Q3 2014 · Sep 30, 2014 $35M
Sga Expense Q3 2014 · Sep 30, 2013 $4.82M
Sga Expense Q3 2014 · Sep 30, 2013 $13.39M
Rd Expense Q3 2014 · Sep 30, 2014 $11.27M
Rd Expense Q3 2014 · Sep 30, 2014 $26.46M
Rd Expense restated Q3 2014 · Sep 30, 2013 $5.93M
Rd Expense restated Q3 2014 · Sep 30, 2013 $30.2M
Net Income Q3 2014 · Sep 30, 2014 −$20.09M
Net Income Q3 2014 · Sep 30, 2014 −$57.96M
Net Income restated Q3 2014 · Sep 30, 2013 −$11.9M
Net Income restated Q3 2014 · Sep 30, 2013 −$46.5M
Operating Income Q3 2014 · Sep 30, 2014 −$18.26M
Operating Income Q3 2014 · Sep 30, 2014 −$56M
Operating Income restated Q3 2014 · Sep 30, 2013 −$11.02M
Operating Income restated Q3 2014 · Sep 30, 2013 −$44.43M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $0
Revenue Q3 2014 · Sep 30, 2014 $10.08M
Revenue Q3 2014 · Sep 30, 2014 $10.08M
Stock Issued Q3 2014 · Apr 17, 2013 8.22M sh
Stock Issued Q3 2014 · Jul 31, 2012 8.63M sh